The best kept secrets in business are often the ones you actually want your employees to be able to read like an open book. This might sound like a paradox, but consider the effort and resources companies expend each year in trying to drive transparent decision making so employees get the information they need when they need it. Unfortunately this ususally ends up in data mart on top of data model, questions on top of queries and a whole lot of confusion. So, if raw data rarely leads to insight and even less generates the kind of information that decision makers can act on, what can you...
Submitted by Gopkiran Rao on Monday, February 6, 2012 - 10:54pm
- Login or register to post comments
Submitted by SMedberry on Saturday, February 4, 2012 - 6:41pm
The US Government is once again going through the process of redefining how it prices drugs that are purchased for the Medicaid program. The last time this occurred was as a direct result of the Deficit Reduction Act and cascaded into 2 years of turmoil as an interim rule was created that was later succeeded by a final rule which changed much of what was in the interim rule.
Late last week, the CMS came out with its long expected AMP rule that responds to changes mandated by the Affordable Care Act of 2009 (also known as Health Care Reform). This proposed rule can be found at:...
Submitted by dweiss on Thursday, January 26, 2012 - 7:43am
At this weeks, ACI conference, John Shakow (King and Spaulding LCC), Kathleen Petersen (Epstein, Becker, & Green, P.C.) and I discussed the history of the program, current operational and management issues and what to anticipate moving forward. While we await guidance from CMS on AMP and HRSA on the refund process, there were interesting points raised. First that there is general consensus that restatements of 340B prices resulting in undercharging Covered Entities cannot be argued for transactions that occurred after the effective date of the statute. There is a case in which the...
Submitted by Sean Cassidy on Tuesday, January 24, 2012 - 10:53am
Interesting look (http://www.nytimes.com/2012/01/22/business/apple-america-and-a-squeezed-...) at some of the reasons why High Tech manufacturing and its supply chain have moved away from the U.S. over the past 15 years. The general gist from this piece is that time-to-market issues are more paramount than labor...
Submitted by dweiss on Tuesday, January 3, 2012 - 12:05pm
340B price accuracy and mandated refunds is a top of mind topic for most Contract and Chargeback departments today. For those interested, please attend the 9:15 session at the upcoming ACI conference in NYC (January 25-26). Kathleen Peterson of Epstein, Becker and Green and John Shakow of King & Spalding will also present with me. After the event, be sure to check back here at the Model N blog for post event commentary and perspectives.
Submitted by Zack Rinat on Friday, December 23, 2011 - 10:34am
December was a special month for Model N as one of our long-term and most innovative customers, Avago Technologies, was awarded the 2011’s “Best Financially Managed Semiconductor Company” at The Global Semiconductor Alliance’s (GSA) Annual Awards Dinner and Celebration. I attended the event and had the opportunity to join Sanjay Mehrotra, President & CEO of SanDisk in announcing the nominees and presenting the EMEA award to Dialog Semiconductor.
The award was one of only a dozen given to leading semiconductor companies at an event of over 2,000 industry stakeholders...